|
⚲
|
| Keyboard |
| Aspire Biopharma Holdings Inc
✚
|
|
|---|---|
| CIK # | 0001847345 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001847345] | |
| 10-Q | [0001847345] | |
| 3 | [0001847345] | |
| 4 | [0001847345] | |
| 8-K | [0001847345] | |
| SC 13D | [0001847345] | |
| SC 13G | [0001847345] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aspire Biopharma Holdings Inc ASBP
Common Stock, par value $0.0001
|
2025-06-05 | Buy | 10,500 | $0.39 | 4,095 |
|
Aspire Biopharma Holdings Inc ASBP
Common Stock, par value $0.0001
|
2025-06-04 | Buy | 9,500 | $0.39 | 3,705 |
|
Aspire Biopharma Holdings Inc PWUPU
Class A Ordinary Shares, par value $0.0001
|
2023-08-18 | Sell | 4,317,500 | ||
|
Aspire Biopharma Holdings Inc PWUPU
Class A Ordinary Shares, par value $0.0001
|
2023-05-18 | Conversion | 7,187,500 | ||
|
Aspire Biopharma Holdings Inc PWUPU
Class B Ordinary Shares · derivative
|
2023-05-18 | Conversion | 7,187,500 |